| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Artificial intelligence for clinical oncology
|
Kann, Benjamin H.
|
|
|
39 |
7 |
p. 916-927
|
article
|
| 2 |
Care without a compass: Including patients with cancer in COVID-19 studies
|
Friese, Christopher R.
|
|
|
39 |
7 |
p. 895-896
|
article
|
| 3 |
Cavity macrophages stop anti-tumor T cells
|
Rodriguez, Paulo C.
|
|
|
39 |
7 |
p. 900-902
|
article
|
| 4 |
Durvalumab with olaparib and paclitaxel for high-risk HER2-negative stage II/III breast cancer: Results from the adaptively randomized I-SPY2 trial
|
Pusztai, Lajos
|
|
|
39 |
7 |
p. 989-998.e5
|
article
|
| 5 |
Is glucose the scapegoat for tumor evasion?
|
Raines, Lydia N.
|
|
|
39 |
7 |
p. 907-909
|
article
|
| 6 |
I-SPY2 platform: New lessons from the olaparib and durvalumab combination in breast cancer treatment
|
Perez-Garcia, Jose
|
|
|
39 |
7 |
p. 902-904
|
article
|
| 7 |
Learning from BISCAY: The future of biomarker-based trial design in bladder cancer
|
Meza, Luis
|
|
|
39 |
7 |
p. 910-912
|
article
|
| 8 |
N6-Methyladenosine on mRNA facilitates a phase-separated nuclear body that suppresses myeloid leukemic differentiation
|
Cheng, Yuanming
|
|
|
39 |
7 |
p. 958-972.e8
|
article
|
| 9 |
Oncogenic mutations drive intestinal cancer initiation through paracrine remodeling
|
Yan, Helen H.N.
|
|
|
39 |
7 |
p. 913-915
|
article
|
| 10 |
Progress and potential: The Cancer Moonshot
|
Sharpless, Norman E.
|
|
|
39 |
7 |
p. 889-894
|
article
|
| 11 |
Single-cell dissection of cellular components and interactions shaping the tumor immune phenotypes in ovarian cancer
|
Hornburg, Milena
|
|
|
39 |
7 |
p. 928-944.e6
|
article
|
| 12 |
Stepwise evolution of therapy resistance in AML
|
Gui, Philippe
|
|
|
39 |
7 |
p. 904-906
|
article
|
| 13 |
The AML microenvironment catalyzes a stepwise evolution to gilteritinib resistance
|
Joshi, Sunil K.
|
|
|
39 |
7 |
p. 999-1014.e8
|
article
|
| 14 |
The loss of RNA N 6-adenosine methyltransferase Mettl14 in tumor-associated macrophages promotes CD8+ T cell dysfunction and tumor growth
|
Dong, Lihui
|
|
|
39 |
7 |
p. 945-957.e10
|
article
|
| 15 |
The role of exhaustion in CAR T cell therapy
|
Delgoffe, Greg M.
|
|
|
39 |
7 |
p. 885-888
|
article
|
| 16 |
Tim-4+ cavity-resident macrophages impair anti-tumor CD8+ T cell immunity
|
Chow, Andrew
|
|
|
39 |
7 |
p. 973-988.e9
|
article
|
| 17 |
Translating inspiration from COVID-19 vaccine trials to innovations in clinical cancer research
|
Choudhury, Noura J.
|
|
|
39 |
7 |
p. 897-899
|
article
|
Journal description